Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma. [electronic resource]
Producer: 20020926Description: PI31-6 p. digitalISSN:- 1234-1010
- Adult
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Constipation -- chemically induced
- Diphosphonates -- administration & dosage
- Disorders of Excessive Somnolence -- chemically induced
- Dizziness -- chemically induced
- Drug Resistance, Neoplasm
- Female
- Humans
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Myeloma Proteins -- analysis
- Osteolysis -- drug therapy
- Pain -- drug therapy
- Pamidronate
- Remission Induction
- Thalidomide -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.